The use of Nisha Aamlaki Powder and Brahmi Powder, combined with walking, to manage Type 2 Diabetes.

Efficacy of Nisha Aamlaki Churna and Brahmi Churna along with Chankraman in the management of Madhumeha (Type 2 Diabetes) An open randomized Comparative clinical Study. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090043

Enrollment

200

Registered

2025-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nisha Aamlaki Churna : 5 Grams, oral route, Two times ( Morning and Evening) For 10 weeks. Control Intervention1: Brahmi churna: 5 Grams, oral route, Two times ( Morning and Evening)

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both male and female sexes from age group 20-60 years. Signs and symptoms of Madhumeha. Fasting Blood Plasma glucose. Greater than 7.0 mmol/l (126mg/dl) OR Post Prandial Blood Plasma glucose. Greater than 11.1 mmol/l (200mg/dl). BMI Greater than 23 Kg/m2 to 30 Kg/m2.

Exclusion criteria

Exclusion criteria: Patients of Diabetes mellitus receiving Insulin or taking allopathic medicine. Patients having chronic complications of Diabetes mellitus. Micro vascular Retinopathy, Neuropathy and Nephropathy. Macro vascular Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. Other chronic debilitating disease like STD etc.

Design outcomes

Primary

Measure	Time frame
Nisha Aamlaki Churna and Brahmi Churna along with Chankraman is effective in the management Madhumeha (Type 2 Diabetes).Timepoint: 10 Weeks	—

Secondary

Measure	Time frame
nilTimepoint:	—

Countries

India

Contacts

Public ContactProf Dr Rekha Phull

FIMS SGT University

rekha.ayurveda@sgtuniversity.org9555953332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026